Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
28
29
Next >
Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead
March 10, 2022
Tickers
AMZN
AVGO
AZN
BIO
Tags
MTD
BIO
CMG
From
InvestorPlace
BioNTech, Regeneron To Evaluate FixVac-Based Cancer Vaccine/Libtayo Combo In NSCLC
March 08, 2022
Tickers
BNTX
REGN
SNY
Tags
Biotech
Contracts
REGN
From
Benzinga
3 Top Healthcare Stocks to Buy for March
March 06, 2022
Tickers
AMGN
CVS
REGN
SNY
Tags
Market News
CVS
UNH
From
Motley Fool
2 Top Growth Stocks That Are Also Generating Billions in Free Cash
March 05, 2022
Tickers
ARKK
BTC
COIN
REGN
Tags
REGN
Recent Press Releases
BTC
From
Motley Fool
Here's Why This Under-the-Radar Biotech Is at the Top of My Buy List
March 04, 2022
Tickers
BNTX
GSK
LLY
PFE
Tags
LLY
PFE
VIR
From
Motley Fool
WHO Conditionally Recommends Merck's COVID-19 Antiviral Pill For High-Risk Patients
March 03, 2022
Tickers
MRK
REGN
Tags
REGN
General
Health Care
From
Benzinga
Viatris Just Snagged a Major FDA Approval
March 03, 2022
Tickers
ABBV
NVS
REGN
RHHBY
Tags
Market News
NVS
SNY
From
Motley Fool
Is Intellia a Good Gene-Editing Stock to Buy Now?
March 03, 2022
Tickers
NTLA
REGN
Tags
REGN
Recent Press Releases
Market News
From
Motley Fool
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
JNJ
IBB
AMRS
From
Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
March 01, 2022
Tickers
NTLA
REGN
Tags
Market News
NTLA
Trading Ideas
From
Benzinga
Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach
February 28, 2022
Tickers
GSK
LLY
NNVC
REGN
Tags
LLY
Penny Stocks
NanoViricides
From
Benzinga
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
February 25, 2022
Tickers
CLOV
CRL
CSII
FFIE
Tags
KOD
Market Insight, Financial Articles
CSII
From
InvestorPlace
7 Low Volatility Stocks to Buy Right Now for Steady Returns
February 24, 2022
Tickers
BRK-B
GRMN
INFY
KO
Tags
INFY
NYSE:KO,NASDAQ:REGN,NASDAQ:TXN,NYSE:INFY,NYSE:GRMN,NYSE:NOC,NYSE:BRK/B
REGN
From
InvestorPlace
Why Kodiak Sciences Stock Is Cratering Today
February 23, 2022
Tickers
KOD
REGN
Tags
Recent Press Releases
REGN
KOD
From
Motley Fool
KOD Stock Alert: Why Is Kodiak Sciences Plunging 80% Today?
February 23, 2022
Tickers
KOD
REGN
Tags
NASDAQ:KOD,NASDAQ:REGN
KOD
REGN
From
InvestorPlace
Palo Alto Is Leading the Nasdaq Higher, but 1 Biotech Is Getting Crushed Wednesday
February 23, 2022
Tickers
KOD
PANW
REGN
Tags
Recent Press Releases
REGN
KOD
From
Motley Fool
Why Kodiak Sciences Shares Are Plunging Today
February 23, 2022
Tickers
KOD
REGN
Tags
Market News
Benzinga
Trading Ideas
From
Benzinga
Is Moderna the Next Gilead or the Next Regeneron?
February 22, 2022
Tickers
GILD
MRK
MRNA
REGN
Tags
Hot Stocks
REGN
NASDAQ:MRNA,NASDAQ:GILD,NYSE:MRK,NASDAQ:REGN
From
InvestorPlace
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers
ABCL
AGIO
ARNA
ATXI
Tags
ATXI
ARNA
SNY
From
Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
Tickers
AGIO
AZN
BMY
GMED
Tags
GSK
News
SNY
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
RHHVF
RHHBF
NVS
From
Benzinga
3 Top Biotech Stocks to Buy for the Long Haul
February 17, 2022
Tickers
MRNA
REGN
VRTX
Tags
Recent Press Releases
VRTX
REGN
From
Motley Fool
5 Value Stocks To Watch In The Healthcare Sector
February 14, 2022
Tickers
FONR
QURE
REGN
SURF
Tags
Benzinga
QURE
THC
From
Benzinga
Lilly's Antibody Receives FDA Emergency Use Nod For Mild-To-Moderate COVID-19
February 14, 2022
Tickers
ABCL
LLY
REGN
Tags
Briefs
ABCL
News
From
Benzinga
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
Tickers
GSK
ICPT
LLY
REGN
Tags
LLY
XBI
VKTX
From
Motley Fool
Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B
February 10, 2022
Tickers
ALNY
NVS
REGN
Tags
Benzinga
Trading Ideas
Market News
From
Benzinga
Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis
February 10, 2022
Tickers
REGN
SNY
Tags
Briefs
News
SNY
From
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Tickers
AGLE
ALNY
ALVR
ARMP
Tags
ALNY
DXCM
News
From
Benzinga
10 Biggest Price Target Changes For Tuesday
February 08, 2022
Tickers
CRNC
DDOG
MCK
REGN
Tags
Pre/Market Outlook
DDOG
TTWO
From
Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
REGN
GSK
PFE
From
MarketWatch
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.